# Haider Afzal, M.D. – FDA Inspection, Oct 4, 2024

Source: https://www.keypedia.com/records/fda_inspections/haider-afzal-md/c8a59d7f-73ab-4cdb-b8a4-95d91ec0b74b
Source feed: FDA_Inspections

> FDA inspection 1250905 of Haider Afzal, M.D., October 04, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250905
- Company Name: Haider Afzal, M.D.
- Inspection Date: 2024-10-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 3

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)

Company: https://www.keypedia.com/companies/haider-afzal-md/6809bf21-85a2-40d7-8fed-72f4443f9527

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9